Evidence map›Paper›PMID 38157366›Full record

ArticlePLoS pathogens2023

Roles of epidermal growth factor receptor, claudin-1 and occludin in multi-step entry of hepatitis C virus into polarized hepatoma spheroids.

Chui-Wa So, Marion Sourisseau, Shamila Sarwar, Matthew J Evans, Glenn Randall

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Identification of claudin-3 as an entry factor for rat hepacivirus.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Expression of CLDN1 and EGFR in PTC.Discover oncology · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Chui-Wa SoDepartment of Microbiology, The University of Chicago, Chicago, Illinois, United States of America.
Marion SourisseauDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Shamila SarwarDepartment of Microbiology, The University of Chicago, Chicago, Illinois, United States of America.
Matthew J EvansDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Glenn RandallDepartment of Microbiology, The University of Chicago, Chicago, Illinois, United States of America.ORCID 0000-0001-7417-3615
University of Chicago · USIcahn School of Medicine at Mount Sinai · US

Funding

Hepatitis C Virus Trafficking in HepatocytesR01AI137514 · NIAID · UNIVERSITY OF CHICAGO · PI Glenn C Randall · 2019 to 2026
$2.7M
NIAID NIH HHS R01 AI137514
6 · The paper itself

Abstract

The multi-step process of hepatitis C virus (HCV) entry is facilitated by various host factors, including epidermal growth factor receptor (EGFR) and the tight junction proteins claudin-1 (CLDN1) and occludin (OCLN), which are thought to function at later stages of the HCV entry process. Using single particle imaging of HCV infection of polarized hepatoma spheroids, we observed that EGFR performs multiple functions in HCV entry, both phosphorylation-dependent and -independent. We previously observed, and in this study confirmed, that EGFR is not required for HCV migration to the tight junction. EGFR is required for the recruitment of clathrin to HCV in a phosphorylation-independent manner. EGFR phosphorylation is required for virion internalization at a stage following the recruitment of clathrin. HCV entry activates the RAF-MEK-ERK signaling pathway downstream of EGFR phosphorylation. This signaling pathway regulates the sorting and maturation of internalized HCV into APPL1- and EEA1-associated early endosomes, which form the site of virion uncoating. The tight junction proteins, CLDN1 and OCLN, function at two distinct stages of HCV entry. Despite its appreciated function as a "late receptor" in HCV entry, CLDN1 is required for efficient HCV virion accumulation at the tight junction. Huh-7.5 cells lacking CLDN1 accumulate HCV virions primarily at the initial basolateral surface. OCLN is required for the late stages of virion internalization. This study produced further insight into the unusually complex HCV endocytic process.

Indexed as

Claudin-1HepacivirusHepatitis CLiver NeoplasmsCarcinoma, HepatocellularClathrinErbB ReceptorsHumansOccludinVirus InternalizationClathrinClaudin-1CLDN1 protein, humanEGFR protein, humanErbB ReceptorsOccludinOCLN protein, human

Identifiers

PMID38157366
PMCPMC10756512
OpenAlexW4390413021

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.